After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine looks like it may descend into acrimony.
Germany's vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech's COVID-19 vaccine Comirnaty, saying it seems less likely to cause
Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca's SGLT2 inhibitor Forxiga, after NICE backed NHS use of the drug in draft
Merck & Co and Ridgeback's oral antiviral molnupiravir has been approved in its first market – the UK – as a treatment for people with mild to moderate COVID-19 who are at increased ris
Novavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other regulators in India, the Philippines and other countries to f
The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation